Selegiline to Zelapar Switch Study in Parkinson Disease Patients
NCT00640159
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Parkinson's Disease
Interventions
DRUG:
Zelapar
Sponsor
Baylor College of Medicine